Clinical Trials Browser

Phase 1 × Terminated × Uveal Melanoma × Clear all

Uveal Melanoma, Melanoma

NCT03746431 2026-01-07

A Phase 1 Study of [225Ac]-FPI-1434 Injection

BreastDermatologicEndocrineGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05047536 2025-12-19

KZR-261 in Subjects With Advanced Solid Malignancies

Phase 1 Terminated

61 enrolled 25 charts

DermatologicGastrointestinalOther solid neoplasmThoracic

Uveal Melanoma, Melanoma, Mesothelioma, Neoplasm Metastasis, Colorectal Neoplasms

NCT04935229 2025-10-22

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Phase 1 Terminated

67 enrolled

Dermatologic

Uveal Melanoma

NCT05576077 2025-03-10

STARLING

Phase 1 Terminated

31 enrolled

BreastDermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT04879017 2024-04-25

FHD-286 in Subjects With Metastatic Uveal Melanoma

Phase 1 Terminated

76 enrolled

Dermatologic

Uveal Melanoma

NCT02601378 2022-09-29

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

Phase 1 Terminated

107 enrolled

Dermatologic

Uveal Melanoma

NCT02029690 2020-09-25

TRAP

Phase 1 Terminated

85 enrolled

CNSDermatologicGastrointestinal

Uveal Melanoma, Carcinoma, Glioma, Carcinoma, Hepatocellular

NCT00002947 2014-07-02

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Phase 1 Terminated

35 enrolled

CNSDermatologicEndocrineGenitourinaryHead & NeckThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Central Nervous System Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00005841 2014-05-22

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1 Terminated

15 enrolled

Dermatologic

Uveal Melanoma, Melanoma

Clinical Trials

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

A Phase 1 Study of [225Ac]-FPI-1434 Injection

KZR-261 in Subjects With Advanced Solid Malignancies

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

STARLING

FHD-286 in Subjects With Metastatic Uveal Melanoma

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

TRAP

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma